| |
Reality Of MedTech In 2025
|
| With Michelle Lovato (Founder/CEO, NasalAid), James Huie (Corporate & Securities Partner, Wilson Sonsini). |
| Venue, To Be Announced, San Francisco |
|
Feb 13 (Thu) , 2025 @ 06:00 PM
| |
FREE |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
Join us for an eye-opening panel discussion on the "Reality of MedTech 2025", where we will explore the pitfalls & challenges of the MedTech journey. Learn what paths to avoid & how to set yourself up for sustainable success in this dynamic & evolving industry.
Panelists
James Huie is a corporate & securities partner at Wilson Sonsini's San Francisco office, where he leads one of the nation's most active practices representing venture-backed companies. He advises life sciences & technology companies on corporate matters, mergers & acquisitions, IPOs, strategic partnerships, & private equity & debt financings. In addition to working with companies, James represents venture capital firms & other investors in financing transactions. He also serves on the investment committee for the firm's affiliated fund, the WS Investment Company.
Michelle Lovato is the founder & CEO of NasalAid. A medical device company focused on improving nasal breathing. She is a Silicon Valley native & the daughter of two inventors. She has spent the last 10 years in medtech & has helped millions of patients breathe better.
Why Attend?
Gain insights into the most common pitfalls MedTech companies face & how to avoid them.
Learn strategies for scaling & sustaining success in the MedTech space.
Engage in meaningful discussions with industry leaders & peers.
Agenda:
6:00 PM: Open & Network
6:30 PM: Partner Introductions
6:45 PM: Panel Discussion
7:45 PM to Close: Networking
Don't miss this chance to gain insider knowledge & connect with the MedTech community as we look ahead to 2025 & beyond!
|
|
|
|
|
|
|
|
